BeStock  
Stocks › Biotechnology › XENE

Xenon Pharmaceuticals XENE

US equityMarket cap rank #2343Biotechnology
$37.57 −$0.45 (-1.18%)
Market closed · Oct 6, 12:20 am ET · Last extended-hours $37.72 +0.40%
Open$38.02
Prev close$38.02
Day range$37.00 – $38.23
Volume1.70M
Market cap$3.64B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-7.9x
CheapRich

Near the top of its 5-year range · 100th percentile, 5-year average -15.1x

Price / book2.9x
CheapRich

Near the bottom of its 5-year range · 7th percentile, 5-year average 4.2x

#3607 of 5315 stocks by PB (1 = cheapest)

P/E over five years

-24x-18x-12x-7xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$41.30
Price vs. fair value-9.0%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 2.93 – 4.21 7% (cheaper than usual) #3607 of 5315 (1 = cheapest)
PE -7.93 -7.63 -15.12 100% (pricier than usual) –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$41.30
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on XENE.

Leave a comment

Scroll to Top